12:23 PM EST - Amorfix Life Sciences : announced its operational and financial results for the year ended March 31, 2011. For the year ended March 31, 2011 the Company reported a net loss from operations of $3,330,437 ($0.07 per share) compared to a net loss of $4,857,038 ($0.10 per share) for the year ended March 31, 2010. For the year ended March 31, 2011 revenue from license fees was $1,030,600 compared to $nil for the year ended March 31, 2010. Amorfix Life Sciences
shares T.AMF are trading up $0.035 at $0.26.
